Bausch Health Companies (BHC) FCF Payout Ratio (2009 - 2014)

Bausch Health Companies (BHC) posted FCF Payout Ratio of 0.01 for Q1 2014, up 167577.71% sequentially from 0.0 in Q4 2013.

Bausch Health Companies (BHC) FCF Payout Ratio (2009 - 2014) Analysis & Trends

Bausch Health Companies has reported FCF Payout Ratio for 6 years, with the latest figure at 0.01 in Q1 2014.

Quarterly FCF Payout Ratio changed N/A year-over-year to 0.01 in Q1 2014, while the trailing twelve-month figure through Jun 2014 was 0.0 (down 14.46% YoY) and the FY2017 annual result came in at 0.01, up 74.8% from the prior year.
FCF Payout Ratio grew to 0.01 in Q1 2014 per BHC's latest filing, from 0.0 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 0.35 in Q1 2010 and troughed at 29.25 in Q4 2010.
A 5-year average of 2.85 and a median of 0.05 in 2013 frame the typical range for FCF Payout Ratio.
The sharpest annual moves came in 2010 and 2012: FCF Payout Ratio plunged 25345.73% in 2010, then soared 158.22% in 2012.
Over 5 years, FCF Payout Ratio stood at 29.25 in 2010, then soared by 99.44% to 0.16 in 2011, then jumped by 158.22% to 0.09 in 2012, then sank by 100.0% to 0.0 in 2013, then jumped by 167577.71% to 0.01 in 2014.
According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.01, 0.0, and 0.01 for Q1 2014, Q4 2013, and Q3 2013 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	-
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	0.41
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-0.83
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.42
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Bausch Health Companies	2.57 Bn	732.63 Mn	2.10 Bn	-

Download Data